Catalyst Wire Dossier Catalyst Wire Dossier

Vildagliptin

vildagliptin
Drug timelines are a Plus or Pro feature.

91 regulatory and trial events tracked for Vildagliptin, covering 2007-05-09 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM [Phase 4]

See pricing